共 9 条
[2]
Targeting IL-17 with ixekizumab in patients with psoriasis.[J].Beatrice Dyring-Andersen;Lone Skov;Claus Zachariae.Immunotherapy.2015, 0
[8]
Wnt5a – a potential factor linking psoriasis to metabolic complications.[J].Sascha Gerdes;Matthias Laudes;Katrin Neumann;Hansjoerg Baurecht;Ulrich Mrowietz.Exp Dermatol.2014, 6

